Joseph Rubinfeld

Joseph Rubinfeld

Plus aucun poste en cours
93 ans
Health Technology
Consumer Services
Consumer Non-Durables

Profil

Joseph Rubinfeld is the founder of Amgen, Inc. (1980), SuperGen, Inc. (1991), and Vivacitas Oncology, Inc. (2015).
He held the title of Chief Operating Officer & Vice President at Amgen, Inc. and Director & Chief Scientific Officer at SuperGen, Inc. Dr. Rubinfeld is also the founder of Imcure Therapeutics, Inc. He held former positions as Vice Chairman at Quark Pharmaceuticals, Inc., Independent Director at LadRx Corp.
(2012-2016), Director at Sarepta Therapeutics, Inc., Director at Regenicin, Inc. (2010-2016), Senior Director at Cetus Corp.
(1968-1980), Independent Director at Amarantus Bioscience Holdings, Inc. (2014-2016), Research Scientist at Colgate-Palmolive Co., and Research Scientist at Schering-Plough Corp.
Dr. Rubinfeld received his graduate and doctorate degrees from The Trustees of Columbia University in The City of New York and his undergraduate degree from The City College of New York.

Anciens postes connus de Joseph Rubinfeld

SociétésPosteFin
LADRX CORPORATION Directeur/Membre du Conseil 26/12/2016
REGENICIN, INC. Directeur/Membre du Conseil 26/12/2016
AMARANTUS BIOSCIENCE HOLDINGS, INC. Directeur/Membre du Conseil 26/12/2016
Fondateur 08/02/2005
AMGEN INC. Fondateur 01/01/1983
Voir l'expérience en détail de Joseph Rubinfeld

Formation de Joseph Rubinfeld

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

62

Relations au 1er degré

14

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées14

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Services

  1. Bourse
  2. Insiders
  3. Joseph Rubinfeld
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT